Commentary

Video

Exploring Newly Released Data in GU and GI Cancers: Drs Grivas and Marshall

OncLive® will be LIVE with OncLive® News Network: On Location at the 2024 ASCO Annual Meeting. Each day, we will broadcast a series of interviews with top thought leaders, to learn their thoughts and reactions to data presented across oncology during the conference.

Related Videos
Rocio Garcia-Carbonero, MD
Daniel King, MD, PhD
Camrelizumab plus rivoceranib vs sorafenib as first-line therapy for unresectable hepatocellular carcinoma (uHCC): Final overall survival analysis of the phase 3 CARES-310 study
Shubham Pant, MD, MBBS
John L. Marshall, MD
Petros Grivas, MD, PhD
Noopur S. Raje, MD
Benjamin Levy, MD
Paolo Tarantino, MD
Sujith Samarasinghe, MD